You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pyrexia

Showing 1 - 25 of 9,359
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pyrexia Trial in Zürich (Actemra)

Recruiting
  • Pyrexia
  • Zürich, Switzerland
    University Hospital Zurich, Clinic of Dermatology
Sep 29, 2021

Malignant Melanoma Trial in Worldwide (Dabrafenib, Trametinib)

Completed
  • Malignant Melanoma
  • Rosario, Sante Fe, Argentina
  • +99 more
Oct 14, 2021

Cardiac Arrest, Postresuscitation Encephalopathy Trial in Vienna (CAERVest cooling device)

Withdrawn
  • Cardiac Arrest
  • Postresuscitation Encephalopathy
  • CAERVest cooling device
  • Vienna, Austria
    Medical University of Vienna
Sep 22, 2022

Myelodysplastic Syndrome Trial in Japan (SyB C-1101)

Completed
  • Myelodysplastic Syndrome
  • SyB C-1101
  • Nagoya, Aichi, Japan
  • +8 more
Nov 14, 2022

BRAF-/MEK-Inhibition With Dabrafenib and Trametinib in Melanoma

Active, not recruiting
  • Melanoma
  • Dabrafenib and Trametinib
  • Buxtehude, Niedersachsen, Germany
  • +35 more
Aug 25, 2022

Carcinoma, Hepatocellular, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Seoul (Microwave ablation)

Active, not recruiting
Has Results
  • Carcinoma, Hepatocellular
  • +3 more
  • Microwave ablation
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 23, 2023

Cesarean Section Complications, Vaginal Infection, Postoperative Infection Trial in Cairo (10% povidone iodine)

Recruiting
  • Cesarean Section Complications
  • +2 more
  • 10% povidone iodine
  • Cairo, Kasr El Ainy, Egypt
  • +1 more
Jul 14, 2022

Myelodysplastic Syndrome Trial in Japan (SyB C-1101)

Completed
Has Results
  • Myelodysplastic Syndrome
  • SyB C-1101
  • Nagoya, Aichi, Japan
  • +3 more
Nov 14, 2022

Patients With Completely Resected High-risk Stage III Melanoma.

Recruiting
  • Melanoma
  • Bursa, Gorukle, Turkey
  • +9 more
Feb 28, 2022

Myelodysplastic Syndrome Trial in Nagoya, Fukuoka, Tokyo (SyB L-1101)

Completed
Has Results
  • Myelodysplastic Syndrome
  • SyB L-1101
  • Nagoya, Aichi, Japan
  • +2 more
Nov 14, 2022

Mental Health and Sleep Disorder Among Patients Hospitalized and

Completed
  • Covid19
  • Questionnaire
  • Brussels, Belgium
    CHU Brugmann
Mar 28, 2022

Infective Endocarditis in End Stage Renal Disease Patients on

Not yet recruiting
  • Infective Endocarditis
  • End Stage Renal Disease
    • Assiut, Egypt
      Faculty of Medicine-Assiut University
    Jan 11, 2023

    Maternal and Neonatal Risk Factors of HIE

    Not yet recruiting
    • Hypoxic Ischemic Encephalopathy of Newborn
      • (no location specified)
      Feb 27, 2023

      Gastritis, Dyspepsia, Helicobacter Pylori Infection Trial in Xi'an (Esomeprazole, Amoxicillin, Bismuth)

      Completed
      • Gastritis
      • +4 more
      • Xi'an, Shaanxi, China
        Xijing Hosipital of Digestive Disease
      Jan 29, 2023

      Relapsing Remitting Multiple Sclerosis Trial in Portugal (peginterferon beta-1a, interferon beta-1a, interferon beta-1b)

      Completed
      • Relapsing Remitting Multiple Sclerosis
      • peginterferon beta-1a
      • +2 more
      • Amadora, Portugal
      • +14 more
      Nov 23, 2020

      SARS-CoV-2 Infection Trial in Hungary (Favipiravir)

      Completed
      • SARS-CoV-2 Infection
      • Budapest, Hungary
      • +4 more
      Oct 30, 2022

      Aortic Stenosis, Symptomatic Aortic Stenosis, Aortic Regurgitation Trial in Sichuan, Beijing, Hangzhou (SAPIEN XT THV with the

      Active, not recruiting
      Has Results
      • Aortic Stenosis
      • +2 more
      • SAPIEN XT THV with the NovaFlex+ delivery system
      • Sichuan, Chengdu, China
      • +2 more
      Aug 29, 2022

      Postpartum Hemorrhage, Blood Loss, Postoperative, Cesarean Section Complications Trial (Tranexamic acid)

      Not yet recruiting
      • Postpartum Hemorrhage
      • +2 more
      • Tranexamic acid
      • (no location specified)
      Sep 28, 2023

      Aerius Syrup in Pediatric Patients Aged 1-5 Years Old With

      Completed
      Has Results
      • Rhinitis
      • Urticaria
      • (no location specified)
      Feb 7, 2022

      Antibiotics Causing Adverse Effects in Therapeutic Use Trial in Cairo (Group 1: Antibiotic receiving group)

      Recruiting
      • Antibiotics Causing Adverse Effects in Therapeutic Use
      • Group 1: Antibiotic receiving group
      • Cairo, Egypt
        Department of Obstetrics and Gynecology, Kasr Al-Ainy University
      Mar 24, 2022

      NSCLC Trial in Worldwide (Pembrolizumab, Pemetrexed, Carboplatin)

      Completed
      Has Results
      • Non-Small Cell Lung Cancer
      • Aurora, Colorado
      • +14 more
      Oct 21, 2022

      Colorectal Cancer Trial in Frankfurt, Zurich (Oxaliplatin, 5-Fluorouracil, Leucovorin)

      Completed
      Has Results
      • Colorectal Cancer
      • Frankfurt, Germany
      • +1 more
      Oct 3, 2022

      Sjögren-Larsson Syndrome Trial in Omaha, Hershey, Fairfax (Active topical NS2 1% dermatologic cream, Vehicle 0.0% NS2

      Completed
      Has Results
      • Sjögren-Larsson Syndrome
      • Active topical NS2 1% dermatologic cream
      • Vehicle placebo 0.0% NS2 dermatologic cream
      • Omaha, Nebraska
      • +2 more
      Nov 16, 2022

      Activated B-cell DLBCL (ABC DLBCL) Trial in United Kingdom, United States (Acalabrutinib)

      Active, not recruiting
      Has Results
      • Activated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL)
      • Los Angeles, California
      • +6 more
      Dec 1, 2022

      Ovarian Tumors Trial in United States (Niraparib, Bevacizumab)

      Active, not recruiting
      Has Results
      • Ovarian Neoplasms
      • Mobile, Alabama
      • +27 more
      Nov 23, 2022